Bioadaptives annual free cash flow
2014
2024
2025
Bioadaptives Free Cash Flow (FCF) History (BDPT)
Bioadaptives reported −$534,025 in free cash flow for fiscal 2025, a decrease of $284,508 from the previous fiscal year, with a free cash flow margin of −2921.68%.
View full Bioadaptives company overviewBioadaptives free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2025 | 2025-12-31 | −$534,025 | −$284,508 | — | −2921.68% |
| 2024 | 2024-12-31 | −$249,517 | −$189,307 | — | −1969.51% |
| 2014 | 2014-12-31 | −$60,210 | — | — | — |
Bioadaptives quarterly free cash flow
Q3.14
Q3.24
Q3.25
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|---|---|---|---|---|
| Q3 2025 | 2025-09-30 | −$151,309 | — | — | −3266.60% |
| Q3 2024 | 2024-09-30 | −$56,342 | — | — | — |
| Q3 2014 | 2014-09-30 | $10,455 | — | — | — |
Bioadaptives free cash flow growth trends
Bioadaptives's latest reported quarter, Q3 2025, generated −$151,309 in free cash flow.
About the metric
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
Calculation and source
How free cash flow is calculated
TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review Bioadaptives filings at SEC.gov ↗